Patent details

EP3843751 Title: COMBINATION PRODUCT OF A BCL-2/BCL-XL INHIBITOR AND A CHEMOTHERAPEUTIC AGENT AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF DISEASES

Basic Information

Publication number:
EP3843751
PCT Application Number:
CN2020105810
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP208477778
PCT Publication Number:
WO2021018240
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATION PRODUCT OF A BCL-2/BCL-XL INHIBITOR AND A CHEMOTHERAPEUTIC AGENT AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF DISEASES
French Title of Invention:
PRODUIT ASSOCIANT UN INHIBITEUR DE BCL-2/BCL-XL ET UN AGENT CHIMIOTHÉRAPEUTIQUE, ET UTILISATION ASSOCIÉE DANS LA PRÉVENTION ET/OU LE TRAITEMENT DE MALADIES
German Title of Invention:
KOMBINATIONSPRODUKT AUS BCL-2/BCL-XL-INHIBITOR UND CHEMOTHERAPEUTIKUM UND VERWENDUNG DAVON ZUR VORBEUGUNG UND/ODER BEHANDLUNG VON ERKRANKUNGEN
SPC Number:

Dates

Filing date:
30/07/2020
Grant date:
27/03/2024
EP Publication Date:
07/07/2021
PCT Publication Date:
04/02/2021
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
27/03/2024
EP B1 Publication Date:
27/03/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
30/07/2024
Expiration date:
30/07/2040
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
20/03/2024
 
 

Name:
Ascentage Pharma (Suzhou) Co., Ltd.
Address:
Unit 701, Building B7, 218 Xinghu Street Suzhou Industrial Park, Suzhou, Jiangsu 215000, China (CN)

Name:
Ascentage Pharma Group Corp Limited
Address:
9/F, Wah Yuen Building 149 Queen's Road Central, Hong Kong, Hong Kong (HK)

Inventor

1

Name:
YANG, Dajun
Address:
China (CN)

2

Name:
FANG, Douglas Dong
Address:
China (CN)

3

Name:
TANG, Qiuqiong
Address:
China (CN)

4

Name:
ZHAI, Yifan
Address:
China (CN)

Priority

1

Priority Number:
PCT/CN2019/098625
Priority Date:
31/07/2019
Priority Country:
World Intellectual Property Office (WIPO) (WO)

2

Priority Number:
202010631089
Priority Date:
03/07/2020
Priority Country:
China (CN)

Classification

IPC classification:
A61K 31/496; A61K 31/55; A61P 35/00; A61P 35/02; A61P 35/04;

Publication

European Patent Bulletin

Issue number:
202413
Publication date:
27/03/2024
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages